International AIDS Vaccine Initiative | IAVI - International AIDS Vaccine Initiative

XVII International AIDS Conference

The XVII International AIDS Conference (AIDS 2008) was held in Mexico City, Mexico from 3-8 August 2008. AIDS 2008 was the first time a country in Latin America hosted the Conference, and IAVI was there to participate in a series of events, as well as to report on the state of AIDS vaccine research and development.
READ MORE >

HIV/AIDS: The Search for a Vaccine

Originally aired as part of BBC World’s Kill or Cure? series, this four-minute documentary features AIDS specialists, researchers, and community workers discussing the impact of HIV/AIDS on their communities and their efforts to find a solution to the epidemic.
WATCH THE VIDEO
DOWNLOAD THE PODCAST

Why the world needs an AIDS vaccine

Despite the international community's best efforts, the HIV pandemic continues unabated. In 2006, more than 39 million people were living with HIV worldwide. Over four million people became newly infected with HIV and an estimated 2.8 million lost their lives to AIDS.
LEARN MORE >

What is a vaccine?

A vaccine is a substance that is introduced into the body to prevent infection or to control disease due to a certain pathogen (any disease-causing organism, such as a virus, bacterium or parasite); the vaccine 'teaches' the body how to defend itself against a pathogen by creating an immune response.
LEARN MORE >

Latest News

^{[what's this?]}

Responding to AIDS: A Call for Japanese Support for Vaccine Development

An opinion piece published in Japan’s Asahi newspaper, authored by Sir Richard Feachem, calls upon Japan to contribute its world-class technology and financial resources to the research and development of preventive vaccines for infectious diseases—particularly an AIDS vaccine.

IAVI releases new policy briefs on approval and procurement of vaccines

These new publications help explain the important processes of ensuring that safe, effective, affordable vaccines are made available to developing countries.

IAVI and Indian Government Announce Results of Phase I AIDS Vaccine Trial

A phase I clinical trial of an MVA-based AIDS vaccine candidate was successfully completed in India, the results of which showed the vaccine candidate had acceptable levels of safety and was well tolerated.

Inovio Expands Research Agreement with IAVI for Use of Novel Vaccine Delivery Technology

As part of an expanded agreement, Inovio Biomedical Corporation will supply IAVI with electroporation delivery devices for use in pre-clinical research on HIV genes and AIDS vaccine candidates. This technology that has the potential to induce significant antibody and T-cell immune responses, both of which scientists believe will be critical to developing a preventive AIDS vaccine.

Mexico City AIDS 2008: Luminaries Call for an AIDS Vaccine to End the Epidemic

Discussions about how to manage AIDS in the long term and how to improve prevention efforts globally took center stage at this year's International AIDS Conference held in Mexico City, with luminaries and vaccine advocates alike calling for continued support for an AIDS vaccine to end the epidemic.

IAVI Launches 2008 AIDS Vaccine Blueprint in Mexico City

With the release of its biennial AIDS Vaccine Blueprint 2008 at the International AIDS Conference today in Mexico City, IAVI seeks to reset both expectations and focus in the search for an AIDS vaccine. A recording of the press conference is available at www.iavi.org/pressbriefing.

MORE NEWS >